With the support by the National Natural Science Foundation of China,the research team directed by Prof.Yang YongQing (杨永清) at Shanghai University of Traditional Chinese Medicine,reported tha transgelin-2 is a therapeutic target for asthmatic pulmonary resistance and its agonist can relax airway smooth muscle cells to provide therapeutic advantages for asthma,which was published in Science Translational Medicine (2018,10(427):eaam8604) and has been selected as the cover story.